Mindray (300760) 43rd Annual J.P. Morgan Healthcare Conference Presentation summary
Event summary combining transcript, slides, and related documents.
43rd Annual J.P. Morgan Healthcare Conference Presentation summary
23 Jul, 2025Industry challenges and solutions
Global healthcare faces rising demand, aging populations, and workforce shortages, prompting a need for operational efficiency and innovative tools, including AI integration across product development.
Low accessibility to high-quality medical resources is addressed through multi-disciplinary assistance and advanced technology.
Integrated product and technology approach
Offers a comprehensive solution combining equipment, consumables, IT, and AI, spanning laboratory, imaging, surgery, cardiology, and more.
Traditional providers focus on single disciplines, while this approach consolidates multiple disciplines for broader impact.
IT and AI systems enable interoperability, automatic data integration, and enhanced clinical decision-making.
AI and digital transformation
AI-driven tools support intelligent decision-making, assisted diagnosis, and telemedicine, improving operational performance.
Qi Yuan, the world's first clinically implemented LLM for critical care, delivers rapid, accurate patient insights and automates medical records.
Latest events from Mindray
- Q3 revenue rebounded with international growth, but YTD net profit declined sharply.300760
Q3 202530 Oct 2025 - H1 2025 revenue and profit declined sharply, but international growth and digital transformation continue.300760
H1 202528 Aug 2025 - Double-digit profit and revenue growth, strong IVD, cardiovascular entry, high dividend.300760
H1 202423 Jul 2025 - Revenue and profit rose 8% year-over-year, led by strong international growth.300760
Q3 202423 Jul 2025 - International growth and strong dividends offset domestic softness; recovery expected.300760
Q1 202523 Jul 2025 - 2024FY saw modest growth and robust international expansion, with recovery expected in late 2025.300760
H2 202423 Jul 2025